We could not find any results for:
Make sure your spelling is correct or try broadening your search.
WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire SUNNYVALE, Calif., Nov. 12, 2024 Company reports record revenue of $1.7 million in...
WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIO Canada NewsWire SUNNYVALE, Calif., Nov. 7...
WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT PR Newswire SUNNYVALE, Calif., Sept...
Everyone is looking for sustainable and clean products. And shares of this firm, which develops and produces precision fermented functional ingredients for the health and wellness, food and To...
WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC. Canada NewsWire SUNNYVALE, Calif., Sept. 5, 2024 The agreement with Kalsec anticipates milestone payments for finalizing...
WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Canada NewsWire SUNNYVALE, Calif., Aug. 12, 2024 Company reports record revenue of $1.0 million, an...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -14.2857142857 | 0.07 | 0.075 | 0.055 | 489520 | 0.0605107 | CS |
4 | -0.02 | -25 | 0.08 | 0.085 | 0.055 | 204469 | 0.06780243 | CS |
12 | -0.04 | -40 | 0.1 | 0.105 | 0.055 | 123432 | 0.07587765 | CS |
26 | -0.05 | -45.4545454545 | 0.11 | 0.145 | 0.055 | 109669 | 0.08696685 | CS |
52 | -0.04 | -40 | 0.1 | 0.145 | 0.055 | 88351 | 0.0934792 | CS |
156 | -0.36 | -85.7142857143 | 0.42 | 0.48 | 0.055 | 99539 | 0.14021008 | CS |
260 | -0.47 | -88.679245283 | 0.53 | 2.24 | 0.055 | 152452 | 0.60651211 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions